参考文献/References:
[1] Yoshida K, Toki F, Takeuchi T,et al.Chronic pancreatitis caused by an autoimmune abnormality: Proposal of the concept of autoimmune pancreatitis[J].Digestive Diseases and Sciences, 1995, 40(7): 1561-1568.
[2] 吕红, 钱家鸣.自身免疫性胰腺炎不同诊断标准的探讨[J].胃肠病学, 2009, 14(1): 4.
[3] Okazaki K, Chari S T, Frulloni L,et al.International consensus for the treatment of autoimmune pancreatitis[J].Pancreatology, 2017, 17(1): 1-6.
[4] Ardila-Suarez O, Abril A, Gómez-Puerta J A.Enfermedad relacionada con IgG4: revisión concisa de la literatura[J].Reumatología Clínica, 2017, 13(3): 160-166.
[5] 李德红,鲁彦,张常青,等.IgG4亚类在疑似恶性肿瘤的自身免疫性胰腺炎中的诊断价值[J].国际检验医学杂志, 2022, 43(1): 126-128.
[6] Sandrasegaran K, Menias C O.Imaging in autoimmune pancreatitis and immunoglobulin G4-related disease of the abdomen[J].Gastroenterology Clinics of North America, 2018, 47(3): 603-619.
[7] 孙备, 冀亮.2016年国际胰腺病学协会《自身免疫性胰腺炎治疗专家共识》解读[J].中国实用外科杂志, 2017, 37(2): 153-156.
[8] Nagpal S J S, Sharma A, Chari S T.Autoimmune pancreatitis[J].American Journal of Gastroenterology, 2018,113(9):1301.
[9] 张艳蓉, 孟茜茜, 辛磊,等.自身免疫性胰腺炎长期预后的研究进展[J].中华胰腺病杂志, 2022, 22(2): 4.
[10] 丁雪梅, 孙文兵.自身免疫性胰腺炎的诊断和治疗[J].中国临床医生杂志, 2010(9): 5.
[11] 高振华, 王军宏, 万玉萍,等.自身免疫性胰腺炎临床治疗体会[J].岭南现代临床外科, 2021, 21(3): 5.
[12] Tacelli M, Celsa C, Magro B,et al.Risk factors for rate of relapse and effects of steroid maintenance therapy in patients with autoimmune pancreatitis: Systematic review and meta-analysis[J].Clinical Gastroenterology and Hepatology, 2019, 17(6): 1061-1072,e8.